Summit addresses need for innovation

Share this article:
Pharmaceutical e-marketing experts called for more innovation in online efforts as the Web enters its second and third incarnations.

“We need to add what is changing to our planning process,” said Paul Ivans, president, Evolution Road Consulting, at IIR's 6th annual ePharma Summit in Philadelphia. “Strategic and tactical planning must include innovation,” he added.

Ivans was among a number of online experts to address 250 e-marketers at the event. Topics of discussion included the rise of the empowered consumer, growth of user-generated content and ways to drive ROI.

 The event featured a thought leader panel discussion including e-marketers from Genentech, Novartis, Lilly and Wyeth.

“A great Web site user experience will result in the holy grail of better patient outcomes and high ROI,” said Frank Visconti, associate director, marketing, at Novartis Pharmaceuticals.

Ben Lei, senior manager, e-marketing at Genentech said that information needs to be easier for consumers to find.

“We need to remove the clutter,” Lei said.

Amy Chafin, specialty therapeutic area marketing manager at Lilly, said her firm is working on finding the right mix through an integration of “sales force, e-detailing, mobile technology and word-of-mouth marketing.”

Share this article:
close

Next Article in News

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?